Werewolf Therapeutics Inc (NASDAQ: HOWL) on Monday, soared 39.02% from the previous trading day, before settling in for the closing price of $2.05. Within the past 52 weeks, HOWL’s price has moved between $1.57 and $8.19.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 5.40% over the past five years. The company achieved an average annual earnings per share of -53.81%. With a float of $30.40 million, this company’s outstanding shares have now reached $39.11 million.
Let’s look at the performance matrix of the company that is accounted for 47 employees. In terms of profitability, gross margin is 80.36%, operating margin of -628.41%, and the pretax margin is -578.8%.
Werewolf Therapeutics Inc (HOWL) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Werewolf Therapeutics Inc is 30.45%, while institutional ownership is 58.53%.
Werewolf Therapeutics Inc (HOWL) Latest Financial update
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.23 earnings per share (EPS) for the period topping the consensus outlook (set at -0.39) by 0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.45 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -53.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.90% during the next five years compared to -13.31% drop over the previous five years of trading.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Trading Performance Indicators
Werewolf Therapeutics Inc (HOWL) is currently performing well based on its current performance indicators. A quick ratio of 12.13 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.35, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.92 in one year’s time.
Technical Analysis of Werewolf Therapeutics Inc (HOWL)
Werewolf Therapeutics Inc (NASDAQ: HOWL) saw its 5-day average volume 2.08 million, a positive change from its year-to-date volume of 0.29 million. As of the previous 9 days, the stock’s Stochastic %D was 80.81%. Additionally, its Average True Range was 0.22.
During the past 100 days, Werewolf Therapeutics Inc’s (HOWL) raw stochastic average was set at 29.24%, which indicates a significant decrease from 70.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 142.83% in the past 14 days, which was higher than the 114.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.12, while its 200-day Moving Average is $4.10. Nevertheless, the first resistance level for the watch stands at $3.23 in the near term. At $3.62, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.96. If the price goes on to break the first support level at $2.51, it is likely to go to the next support level at $2.17. The third support level lies at $1.78 if the price breaches the second support level.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Key Stats
Market capitalization of the company is 124.54 million based on 43,455K outstanding shares. Right now, sales total 19,940 K and income totals -37,370 K. The company made 1,140 K in profit during its latest quarter, and -17,250 K in sales during its previous quarter.
